Double Umbilical Cord Blood Stem Cell Transplantation
Showing 1 - 25 of >10,000
Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,
Recruiting
- Acute Leukemia
- Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
- haploidentical hematopoietic stem cell transplantation
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Aug 9, 2022
Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Malignant Hematological Diseases
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Jul 3, 2023
Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood
Recruiting
- Hematopoietic Malignancy
- +2 more
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Nov 6, 2023
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Stem Cell Transplantation Trial in Durham (Thymic Transplantation for Recipients of UCB transplant)
Terminated
- Stem Cell Transplantation
- Thymic Transplantation for Recipients of UCB transplant
-
Durham, North CarolinaDuke University Health System
Mar 21, 2022
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle
Recruiting
- Acute Biphenotypic Leukemia
- +5 more
- Dilanubicel
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 11, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
ST Elevation Myocardial Infarction Trial in Jakarta Pusat (Umbilical Cord Mesenchymal Stem Cell transplantation)
Not yet recruiting
- ST Elevation Myocardial Infarction
- Umbilical Cord Mesenchymal Stem Cell transplantation
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo Hospital
Jul 5, 2023
Epidermolysis Bullosa Trial in Minneapolis (drug, procedure, radiation)
Active, not recruiting
- Epidermolysis Bullosa
- Cyclophosphamide
- +7 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center and Medical Center
Feb 25, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
- GVHD prophylaxis
-
Duarte, California
- +15 more
Nov 2, 2021
Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- standard medical treatment
- +10 more
-
Beijing, Beijing, Chinathe Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023
MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- unrelated umbilical cord blood
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022
Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Recombinant Interleukin-7
-
Houston, TexasM D Anderson Cancer Center
Jan 26, 2023
Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)
Recruiting
- Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 20, 2022
Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent
Available
- Hematologic Malignancies
- +2 more
- CliniMACS CD34 Reagent System
-
Durham, North CarolinaDuke University Medical Center
Nov 12, 2021
Storage of Umbilical Cord Stem Cells for Treatment of Sickle
Recruiting
- Sickle Cell Disease
- Sickle Cell Trait
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Long Term Follow Up Protocol for NiCord®/CordIn™ Patients
Active, not recruiting
- Patients Transplanted With NiCord/CordIn (Omidubicel)
- NiCord®/CordIn™ (omidubicel)
-
Oakland, California
- +9 more
Oct 31, 2022
Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Recruiting
- Primary Immunodeficiency (PID)
- +4 more
- data collection
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Feb 9, 2022
Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)
Completed
- Mantle Cell Lymphoma
- +6 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2022
Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))
Recruiting
- Mesenchymal Stem Cells
- Mesenchymal Stem Cells (MSCs)
-
Shapingba, Chongqing, ChinaXinqiao Hospital
Nov 24, 2023
Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)
Recruiting
- Acute Leukemia
- +9 more
- Total Body Irradiation 1200 cGy
- +7 more
-
Rochester, New YorkWilmot Cancer Institute
Jun 20, 2022
Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)
Recruiting
- Diabetes Mellitus, Type 1
- Immunologic Deficiency Syndromes
- Sequential transplantation
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 4, 2022
Autism Trial in St. John's (AlloRx)
Recruiting
- Autism
- AlloRx
-
St. John's, Antigua and BarbudaMedical Surgical Associates Center
Oct 25, 2022